Editorial Board

The resources for Female Sexual Dysfunction Online have been developed under the guidance of an Editorial Board of clinical and research experts from leading medical institutions. This panel identifies topics and ensures the materials posted on Female Sexual Dysfunction Online address timely issues and incorporate the most current research findings and state-of-the-art clinical approaches to managing their patients who suffer from this dysfunction.

In keeping with the Female Sexual Dysfunction Online principle of full disclosure, Editorial Board members have been asked to disclose any financial interest or other relationship with any commercial concern(s) related directly or indirectly to their presentation(s) or reviews. This information is acknowledged solely for the information of the participant. Information and opinions represent the viewpoints of the speakers and Editorial Board members of Female Sexual Dysfunction Online. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.

Co-Chairs/Editorial Directors

Paula Amato, MD, is a fertility consultant and an adjunct assistant professor at the Oregon Health and Science University in Portland, Oregon. She received her medical degree from the University of Toronto in 1989, where she also completed her residency in obstetrics and gynecology. She subsequently completed a fellowship in reproductive endocrinology and infertility at the University of California, San Diego. Dr. Amato was awarded an American Obstetricians and Gynecologists Foundation Fellowship (1997–2000) and was a recipient of the Berlex Scholar Award in Basic Science Research in 2001. She is board certified in both obstetrics and gynecology and reproductive endocrinology and infertility. As an academician, she has held faculty appointments at the University of California, San Diego, and at Baylor College of Medicine.

Dr. Amato is active in many professional and community service organizations. She is a former associate editor of Sexuality, Reproduction, & Menopause, a vice chair of the American Society of Reproductive Medicine (ASRM) Sexuality Special Interest Group, and a member of the ASRM Ethics Committee. Her research interests and clinical practice areas include menopause, polycystic ovary syndrome, and infertility.

Dr. Amato has indicated that she has nothing to disclose.

Sandra Ann Carson, MD, is a professor of obstetrics and gynecology at the Warren Alpert Medical School of Brown University and director of the Division of Reproductive Medicine and Infertility at Women and Infants Hospital of Rhode Island in Providence. Dr. Carson earned her medical degree in 1977 and completed her residency in obstetrics and gynecology in 1981 at Northwestern University Medical School. After completing a fellowship in reproductive endocrinology at the Michael Reese Medical Hospital in the University of Chicago Medical Center in 1983, she became a diplomate of the American Board of Obstetrics and Gynecology in 1984 and earned subspecialty certification in reproductive endocrinology and infertility subspecialty certification in 1985. She subsequently held faculty positions at the University of Chicago Pritzker School of Medicine, the University of Tennessee College of Medicine, and at Baylor College of Medicine, where she served as chief of Baylor Assisted Reproductive Technology in the Department of Obstetrics and Gynecology. Dr. Carson is an active clinical practitioner in both the office and operating room where she continues to practice her skills in endoscopic surgery.

Dr. Carson's research has been funded by the National Institutes of Health since 1989, and she was funded in 2000 as the principal investigator for the Reproductive Endocrine Network sponsored by the National Institute of Child Health and Human Development (NICHD). Dr. Carson has written and edited 3 books, more than 50 book chapters, and more than 75 peer-reviewed articles. She is a sought-after lecturer for grand rounds and postgraduate courses. She frequently serves as an ad hoc reviewer for various journals and currently is an associate editor of the American Journal of Obstetrics and Gynecology and is the editor-in-chief of Journal Watch in Women's Health, a publication of the Massachusetts Medical Society.

Nationally, Dr. Carson is active in many professional organizations. She has served as president (2003–2004) of the American Society for Reproductive Medicine and as a member of many of the society's committees.  She also has served as vice president of the American College of Obstetricians and Gynecologists (ACOG) and as secretary-treasurer of the Society for Gynecological Investigation. Currently, Dr. Carson is a member of the NICHD Advisory Council, the NICHD Fertility Preservation Advisory Panel, and the NICHD Subcommittee on Planning and Policy.  She is a consultant to the Center for Devices and Radiological Health Committee of the Food and Drug Administration (FDA) and is a member of the FDA Advisory Committee for Reproductive Health Drugs.  In addition, she serves as an examiner for the American Board of Obstetrics and Gynecology and as director of the Certification of Special Competency in Reproductive Endocrinology and Fertility for the board.

Dr. Carson is engaged in research for the National Institutes of Health, Watson, and Procter & Gamble Pharmaceuticals, Inc. She is a consultant for Procter & Gamble Pharmaceuticals, Inc., Lilly Serono, and Ferring. She is a shareholder of Pfizer and Serono.

Editors

John E. Buster, MD, is a professor in the Division of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at the Warren Alpert School of Medicine at Brown University in Providence, Rhode Island. He received his undergraduate training at Stanford University, and his medical and residency training in obstetrics and gynecology at the University of California, Los Angeles (UCLA), where he later completed a fellowship in reproductive endocrinology. Dr. Buster is board certified in obstetrics and gynecology with a subspecialty certification in reproductive endocrinology and infertility. As an academician, he has held previous faculty appointments at ULCA, the University of Tennessee School of Medicine, and Baylor College of Medicine. As a researcher, he has published more than 200 original articles, book chapters, and reviews on subjects ranging from menopause to advanced infertility-treatment methods in women. He is a reviewer for numerous medical journals, holds memberships in various academic societies, sits on or is chair of numerous committees, and serves as an examiner for the American Board of Obstetrics and Gynecology. Dr. Buster is listed repeatedly in numerous consumer publications as one of "America's Top Obstetricians and Gynecologists," "Best Doctors for Women," and "Best Doctors in America."

Dr. Buster's research includes studies of recurrent pregnancy-loss wastage and the diagnosis of ectopic pregnancy and of preimplantation genetic disorders. He was among the first clinical researchers to study methotrexate as a treatment for ectopic pregnancy and directed the first group to successfully transfer human embryos from a donor into an infertile recipient and achieve full-term pregnancy and birth. He continues to investigate and publish in both of these research areas. Dr. Buster also has been the principal investigator of numerous clinical trials that have studied the impact of percutaneous administration of testosterone on the support and restitution of female sexual desire during the postmenopausal years.

Dr. Buster has received grant support from, is a consultant for, and is a member of the speakers bureau for Procter & Gamble Pharmaceuticals, Inc.

Sheryl A. Kingsberg, PhD, is a clinical psychologist and associate professor in the Departments of Reproductive Biology and Psychiatry at Case Western Reserve University School of Medicine. Since 1991, she has served as staff psychologist of the Department of Obstetrics and Gynecology at University Hospitals of Cleveland. In this capacity Dr. Kingsberg directs inpatient and outpatient psychological care, as well as providing clinical supervision to medical students and psychiatry residents. She also devotes significant time to conducting clinical research and teaching medical students and residents.

Dr. Kingsberg earned her doctorate in 1989 from the University of South Florida in Tampa. Dr. Kingsberg is an active member in numerous national and international organizations including the American Psychological Association, the American Society for Reproductive Medicine (ASRM), the Society for Sex Therapy and Research, the North American Menopause Society (NAMS), the International Society for Women's Sexual Health, the North American Society for Psychosocial Obstetrics and Gynecology, and the Society for Behavioral Medicine. She is currently the chairwoman of the ASRM Sexual Health Special Interest Group and sits on the editorial boards for the NAMS journal Menopause and the ASRM journal, Sexuality Menopause and Reproduction.

Dr. Kingsberg's main research interests are in female sexual function, the psychological aspects of infertility and menopause and enhancing medical school education. In addition to numerous professional presentations, she is well represented in the current literature and sits on the editorial boards of Menopause, The International Journal of Impotence Research, Sexuality Menopause and Reproduction, and Menopause Management. Dr. Kingsberg has authored numerous chapters on topics including, aging and sexuality, oocyte donation, infertility and aging, sexual aversion disorder, and the treatment of psychogenic erectile dysfunction. She has been the principal investigator on a $100,000 research grant to enhance the sexual health curriculum of the Case Western Reserve University Medical School and is currently the principal investigator for two clinical trials on the treatment of hypoactive sexual desire disorder.

Dr. Kingsberg is engaged in research for Procter & Gamble Pharmaceuticals, Inc., Organon, Pfizer, and Solvay. She is a consultant for Procter & Gamble Pharmaceuticals, Inc., Lilly ICOS and Solvay; and she is a member of the speakers bureau for Solvay, Procter & Gamble Pharmaceuticals, Inc., Lilly ICOS, Pfizer and Organon. She is a member of the advisory board of Lilly ICOS.

Ertug Kovanci, MD, is a reproductive endocrinologist and an assistant professor in the Division of Reproductive Endrocrinology and Infertility at Baylor College of Medicine in Houston, Texas. He received his medical degree from Istanbul Medical School in Turkey, where he completed a residency in obstetrics and gynecology in 1992. After working a year as a clinical instructor in obstetrics and gynecology at the Istanbul Medical School, Dr. Kovanci came to the United States for additional postgraduate training. He spent three years (1997–2000) as a postdoctoral trainee in the Division of Maternal Fetal Medicine at the Yale University School of Medicine in New Haven, Connecticut, and for three years (2000–2003) in the Department of Obstetrics and Gynecology at Baylor College of Medicine. He also completed a three-year clinical fellowship in reproductive endocrinology and infertility before joining the faculty of Baylor College of Medicine in 2006. Dr. Kovanci's research interests and clinical practice specialties include in vitro fertilization, premature ovarian failure, and uterine fibroids.

Dr. Kovanci has indicated that he has nothing to disclose.

Mary Lake Polan, MD, PhD, MPH, serves as the chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine and was named the Katharine Dexter McCormick and Stanley McCormick Memorial Professor in 1990 when she moved to Stanford from Yale University.

Dr. Polan specializes in reproductive endocrinology and infertility. She has published more than 130 articles, chapters and books of research in this field. Dr. Polan serves on numerous medical and health committees, including the Institute of Medicine, the National Institutes of Health, the American Society for Reproductive Medicine (ASRM), and the American Medical Women's Association (AMWA). She is a fellow of the American College of Obstetrics and Gynecology and a member of many professional societies. She is a director of Wyeth, Madison, NJ and Quidel Corporation, San Diego, CA, and has a long-standing interest in women's health. She is a member of the Secretary's Advisory Committee on Human Research Protections, U. S. Department of Health and Human Services.

Dr. Polan received a bachelor's degree from Connecticut College and a doctorate in molecular biophysics and biochemistry and a medical degree from Yale University. She completed her residency and reproductive endocrine fellowship in the Department of Obstetrics and Gynecology at Yale University School of Medicine. Dr. Polan received a master's in public health (Maternal and Child Health Program) from the University of California, Berkeley.

Dr. Polan's research interests include the role of cytokines in implantation, the relationship of the central nervous system to peripheral genital response in female sexual function, and the impact of increased collagen turnover in female urinary incontinence. In addition, Dr. Polan is interested in international public health and has initiated a surgical project in Eritrea to repair fistulas resulting from traumatic births. During trips in October 2002 and February 2004, Stanford physicians operated on more than 80 women.

Dr. Polan is a consultant for Procter & Gamble Pharmaceuticals, Inc., and a director and shareholder of Wyeth.

Raymond C. Rosen, PhD, is professor of psychiatry and medicine, and director of the Human Sexuality Program at Robert Wood Johnson Medical School. He is also chief psychologist in the Department of Psychiatry, academic director of the Sleep Disorders Center, and professor of psychology at the Graduate School of Applied and Professional Psychology at Rutgers University in New Brunswick. He received his doctorate in clinical psychology in 1972 from the State University of New York at Stony Brook and post-doctoral fellowship training at Massachusetts General Hospital.

Dr. Rosen is a world-renowned researcher and major contributor to the field of human sexuality. He has authored 8 books and more than 200 book chapters and peer-reviewed articles on diverse aspects of sexuality and sexual dysfunction. He is the past editor of the Annual Review of Sex Research, past president of the International Academy of Sex Research, and vice-chair of the 2nd International Consultation on Sexual Dysfunction. He received the lifetime scientific contribution award from the American Association of Sex Educators, Counselors and Therapists and is the recent recipient of the Masters and Johnson Award for distinguished contributions to Sex Research and Therapy. Dr. Rosen has served as a senior consultant and advisor for the NIH, FDA and pharmaceutical industry and has received more than 50 grants and awards for research in sexual dysfunction. He is a member of many professional organizations and serves on the editorial boards of Archives of Sexual Behavior, The Journal of Sexual Medicine, Menopause and the Annual Review of Sex Research.

Dr. Rosen is engaged in research for Bayer/GlaxoSmithKline, Lilly/ICOS, Pfizer Inc., and Solvay Pharmaceuticals. He is a consultant for Pfizer, Solvay, Procter & Gamble Pharmaceuticals, Inc., Eli Lilly, Bayer Pharmaceuticals, and Johnson & Johnson.

Contributors

Gloria A. Bachmann, MD, is a professor and interim chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Medicine and Dentistry of New Jersey (UMDNJ)–Robert Wood Johnson Medical School in New Brunswick, New Jersey. She also serves as the associate dean of women's health and as the director of the Women's Health Institute. After completing her bachelor's degree at Rutgers University, Dr. Bachmann went on to receive a master's degree from Rutgers Medical School and a medical degree from the University of Pennsylvania Medical School. She completed a four-year residency in obstetrics and gynecology the Hospital of the University of Pennsylvania.

A well-known authority on midlife and older women, Dr. Bachmann is one of the founding members of the International Menopause Society and of the North American Menopause Society. She has served on the editorial boards of Obstetrics and Gynecology (1991–1995) and Managing Menopause (1998–2002) and is a current editorial board member of Maturitas, Menopause, Medical Crossfire, and The Journal of Reproductive Medicine.

Dr. Bachmann's role in advancing the understanding of obstetrics and gynecology has been recognized with numerous awards, including the 1988 Issue of the Year Award by the American College of Obstetricians and Gynecologists (ACOG), the Best Scientific Paper at the 1990 ACOG Annual Meeting, the Lifetime Achievement Award from the Middlesex County (New Jersey) Commission on the Status of Women, the 2001–2002 President's Community Service Award for District III of ACOG, the New Jersey Academy of Medicine's Educator Award, the Hemophilia Association of New Jersey's Humanitarian Award for work with women who have bleeding disorders, and the American Medical Women's Association Gender Equity Award. She also has received numerous awards from the UMDNJ, such as the Best Teacher Award in Family Medicine. From 1996–2002, Dr. Bachmann mentored residents and medical students in research trials that have since received national recognition and in 2000 she was honored by both the Robert Wood Johnson University Hospital and the Women's Health & Counseling Center for advancing the field of Women's Health.

Dr. Bachmann is engaged in research for Johnson & Johnson, National Institutes of Health, Novartis Corporation, Pfizer Inc, and Wyeth Pharmaceuticals and serves as a consultant for Solvay.

Rosemary Basson, MB, BS, FRCP (UK), is the director of the Program in Sexual Medicine at the University of British Columbia (UBC), Vancouver, British Columbia, Canada. She began specializing in internal medicine a great many years ago, subsequently grounded in family medicine in Deep Cove, North Vancouver (1974-1987) and then focused entirely on sexual medicine. After publishing some fifty peer-reviewed articles many focusing on a reconceptualization of human sex response, particularly that of women, Dr. Basson has facilitated an international consensus committee's attempt to revise and expand the definitions of women's sexual dysfunctions.

Dr. Basson is the co-chair for the 2nd International Consensus on Sexual Medicine: Men and Women's Sexual Dysfunctions, now published in book format and imminently freely available on the Web. This is an evidence-based, multi-authored international report on assessment and management of men and women's sexual dysfunctions.

As a clinical professor in the UBC Department of Psychiatry with cross appointment in Ob/Gyn, Dr Basson provides assessment and management consultations to referring doctors across British Columbia. She is extensively involved with undergraduate and postgraduate education and local, national and international continuing medical education as well as clinical research and membership of various scientific committees and editorial boards.

Dr. Basson is a consultant for Pfizer and Solvay.

Diane C. Bodurka, MD, is an associate professor of gynecologic oncology at The University of Texas M. D. Anderson Cancer Center, Houston, Texas, where she is also the co-director of the Ovarian Cancer Screening Program and the program director for the fellowship program in the Department of Gynecologic Oncology.

Dr. Bodurka is a Fellow of the American College of Obstetricians and Gynecologists, a Fellow of the American College of Surgeons, and a member of the American Society of Clinical Oncology (ASCO). She is a member of ASCO's Health Services Research Committee, as well as a member of the Quality of Life Committee of the Gynecologic Oncology Group.

Dr. Bodurka's major research interests include ovarian cancer and health services research, particularly quality of life issues, patient preferences, and outcomes analyses. She has studied depression in ovarian cancer patients, and was a co-investigator on a study to validate the FACT-O, a tool to assess quality of life in patients with ovarian cancer. She has recently been awarded two grants to study patient preferences for treatment outcomes in women at increased risk of breast and ovarian cancer, as well as in women receiving high-dose versus standard chemotherapy. Dr. Bodurka also recently received a National Cancer Institute grant to study quality of life and sexual functioning in women with cervical cancer.

Dr. Bodurda is extremely active in the area of public education. She frequently speaks about ovarian cancer and ovarian cancer screening to community groups. She has also co-chaired three symposia dedicated to women's health issues.

Dr. Bodurka has been a consultant for Merck.

Glenn D. Braunstein, MD, is a professor and vice chair of the Department of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA); he is chair of the Department of Medicine at Cedars-Sinai Medical Center in Los Angeles, where he holds the James R. Klinenberg, MD, chair in medicine.

After earning his medical degree at the University of California, San Francisco, Dr. Braunstein moved to Boston, Massachusetts to pursue his internship and residency at Peter Bent Brigham Hospital and Harvard University Medical School. He completed his training in endocrinology at the National Institutes of Health, Bethesda, Maryland, and Harbor General Hospital, UCLA School of Medicine, and is board certified in internal medicine and the subspecialty of endocrinology, diabetes, and metabolism.

Dr. Braunstein is a member of the North American Menopause Society, the American Association of Clinical Endocrinologists, the American Association of Physicians, the Royal Society of Medicine, and the American Society for Clinical Investigation, among other professional organizations. A past chair of the endocrinologic and metabolic drug advisory committee of the Food and Drug Administration, Dr. Braunstein currently serves on the patient education and advocacy committee of the American Thyroid Association and chairs the media advisory committee for the Endocrine Society.

The Los Angeles Business Journal named Dr. Braunstein "Top Endocrinologist" in 1999, and Best Doctors named him among the "Best Doctors in America" in 2002-2003. His research focuses primarily on reproductive endocrinology and human chorionic gonadotropin. The author of five monographs, including hGC Testing: A Guide for the Testing of Human Chorionic Gonadotropin, Dr. Braunstein has also written more than 150 peer-reviewed papers and nearly 60 book chapters. His published work covers a wide spectrum dealing with pregnancy, human chorionic gonadotropin, ovarian and testicular physiology and pathophysiology, thyroid disease, and pituitary disorders.

Dr. Braunstein serves on the editorial boards of American Family Physician, American Journal of Medicine, and Reviews in Endocrinology and Metabolism. He is a former editor of the Journal of Clinical Endocrinology and Metabolism and former board member of Mt. Sinai Journal of Medicine.

Dr. Braunstein is engaged in research activities and is a consultant for Procter & Gamble Pharmaceuticals, Inc.

Sheryl A. Bushman, DO, received her BS with a double major in chemistry & biology from The State University of New York at Fredonia in 1978. After spending a year in graduate school studying biochemistry and organic chemistry, Dr. Bushman entered osteopathic school, earned her DO in 1984 from the Texas College of Osteopathic Medicine, and went on to complete her internship in Texas and an OB/GYN residency in Detroit. She enjoyed a private medical practice in Kansas City for five years before moving to St. Louis, where she established her own practice and became a residency program director and hospital administrator. Currently, Dr. Bushman is a physician/ partner in a Fort Scott, KS, multi-specialty group. In addition to her private practice, she is professionally active at the national level, having served as president of the American College of Osteopathic Obstetricians and Gynecologists, as a member of the Executive Committee of the National Board of Osteopathic Medical Examiners, as an examiner for the American Osteopathic Board of Obstetricians and Gynecologists and on several other committees.

Dr. Bushman has been featured on the American Osteopathic Association website for her volunteer humanitarian efforts in Haiti, and she has been active for many years in the Friendship Foundation of American-Vietnamese, serving as their medical director in 1995-96 and as a current member of their medical advisory board. As part of that effort she spent one month in 1995 on a volunteer medical mission to Vietnam.

Dr. Bushman is a consultant for Ortho-McNeil Pharmaceutical, Inc., Procter & Gamble Pharmaceuticals, Inc. and Wyeth Pharmaceuticals.

J. Christopher Carey, MD, is a professor of clinical obstetrics and gynecology at the University of Arizona College of Medicine in Tucson and chairman of the department of obstetrics and gynecology at Maricopa Medical Center and Medpro in Phoenix, Arizona, where he is also director of the Phoenix Integrated Residency Program. Prior to his current appointment, he served as vice chairman of Obstetrics and Gynecology at Penn State College of Medicine and chief of Women's Health at the Milton S. Hershey Medical Center.

Dr. Carey received his undergraduate degree from Oklahoma State University in Stillwater and his medical degree from Baylor College of Medicine in Houston, Texas. After completing an obstetrics and gynecology internship and residency at the University of Oklahoma Health Sciences Center in Oklahoma City, Dr. Carey served as professor, vice chairman and residency program director of the University of Oklahoma's OB/GYN department. During his tenure there, he completed a postgraduate training program in sex therapy at The Menninger Institute in Topeka, Kansas, and served as a special assistant for obstetrics at the National Institute of Child Health and Human Development at the National Institutes of Health in Bethesda, Maryland.

Certified by the American Board of Obstetrics and Gynecology and the American Board of Sexology, Dr. Carey has served on numerous professional committees and task forces and has authored more than 70 scientific papers, numerous book chapters and two books. He has also participated in numerous clinical trials and conducted extensive research in the areas of infections in obstetrics and gynecology, prevention of preterm birth, gynecological surgery, and sexual medicine.

For the past 15 years, Dr. Carey has been an oral examiner for the American Board of Obstetrics and Gynecology; he also received an award of research excellence from the Society for Maternal Fetal Medicine and is listed in Best Doctors in America, 4th Ed. Woodward and White for his expertise in vulvar and vaginal disease.

Dr. Carey has indicated that he has nothing to disclose.

Margery Gass, MD, is director of the Menopause and Osteoporosis Center at University Hospital and professor in the Department of Obstetrics and Gynecology at the University of Cincinnati College of Medicine in Cincinnati, Ohio. After receiving a Master's degree in French from Miami University, Dr. Gass earned her medical degree from the University of Cincinnati College of Medicine, where she also completed her internship and residency.

Dr. Gass is the principal investigator at the Cincinnati site of the Women's Health Initiative, and her research areas include the evaluation of hormone replacement therapy in treating osteoporosis and women's attitudes toward menopause and midlife experiences. She is a fellow of the American College of Obstetricians and Gynecologists and a member of numerous professional organizations, including the North American Menopause Society (NAMS). Dr. Gass served as the 2002-2003 NAMS president, co-chaired the NAMS Advisory Panel on Postmenopausal Hormone Therapy, and was selected in 1991 for the American Medical Women's Association master faculty on osteoporosis. In addition to publishing and presenting her findings to medical audiences, Professor Gass speaks frequently to community organizations and conducts public symposia on women's health issues.

Dr. Gass is engaged in research for Eli Lilly and Company, GlaxoSmithKline, Merck & Co, Inc., Pfizer Inc., Procter & Gamble Pharmaceuticals, Inc., and Wyeth Pharmaceuticals. She also serves as a consultant for Aventis, Merck & Co, Inc., and Procter & Gamble Pharmaceuticals, Inc. and as an advisory board member for Eli Lilly and Company, Merck & Company, Inc., and Procter & Gamble Pharmaceuticals, Inc.

Christopher Jayne, MD, FACOG, received a Bachelor of Science from the State University of New York at Albany. He then received a Doctor of Medicine from the State University of New York at Buffalo School of Medicine where he graduated with honors. He completed a residency in Obstetrics and Gynecology at Baylor College of Medicine in Houston where he was recognized for outstanding academic and clinical performance. After his residency, Dr, Jayne served on active duty in the United States Air Force as a staff physician and was promoted to the rank of major. He then founded the Center for Women's Sexual Health at the Women's Hospital of Texas in Houston, the first center on the Gulf Coast devoted to the research and treatment of Female Sexual Dysfunction. He is board certified in Obstetrics and Gynecology, a fellow of the American College of Obstetricians and Gynecologists and a certified sex counselor by the American Association of Sex Educators and Therapists. He is a member of the clinical faculty in the Department of Obstetrics and Gynecology at Baylor College of Medicine.

Dr. Jayne has indicated that he has nothing to disclose.

Rogerio A. Lobo, MD, received his medical degree from Georgetown University Medical School in Washington, DC and completed his residency in Obstetrics and Gynecology at the Chicago Lying-In Hospital at the University of Chicago. He went on to complete a clinical research fellowship in the Division of Reproductive Endocrinology and Infertility at the University of Southern California Medical Center in Los Angeles.

Dr. Lobo has since held numerous teaching positions, including assistant and associate professor in the Department of Obstetrics and Gynecology at the University of Southern California in Los Angeles, where he was later promoted to full professor. In 1995 he came to the Columbia University College of Physicians and Surgeons in New York City, where he was named the Willard C. Rappleye Professor of Obstetrics and Gynecology and chairman of the department. He was also appointed director of the Center for Reproductive Sciences at the College of Physicians and Surgeons and director of the Sloane Hospital for Women, Columbia-Presbyterian Medical Center.

In addition to a successful academic career, Dr. Lobo has served as the director of the Reproductive Endocrinology and Infertility Training Program at the University of Southern California for 11 years. He has provided outside consulting services for many large pharmaceutical laboratories. He has functioned as editor, editorial board member and/or consultant for more than 30 peer-reviewed medical journals in his field and has authored more than 300 articles and 20 books. He is currently editor-in-chief of the Journal of the Society for Gynecologic Investigation and was president of the society in 1997-98. He has edited and contributed chapters to several important medical textbooks; his book Treatment of the Post-Menopausal Woman is in its second edition, and another text, Menopause, was published in early 2000.

Dr. Lobo has done extensive research in various areas of reproductive endocrinology and infertility and has a specific interest in hyperandrogenic disorders and polycystic ovary syndrome. He also carried out extensive research in gamete biology, induction of ovulation, IVF, and estrogen metabolism and the treatment of postmenopausal women.

Dr. Lobo is engaged in research for Merck & Co., Inc., National Institutes of Health, Ortho-McNeil Pharmaceutical, Inc., and Wyeth Pharmaceuticals, and is a consultant for Berlex Laboratories, Eli Lilly & Company, Merck & Co, Inc., Ortho-McNeil Pharmaceutical, Inc., Solvay Pharmaceuticals, Inc., and Wyeth Pharmaceuticals.

Cindy Meston, PhD, is an associate professor of clinical psychology at the University of Texas at Austin. She received her doctorate from the University of British Columbia in 1995 and completed a postdoctoral fellowship in sexual and reproductive medicine at the University of Washington School of Medicine in 1996. With funding from the Social Science Research Council of the Ford Foundation, she completed a two-year fellowship, studying the cognitive processes that mediate the relationship between early childhood sexual abuse and later adult sexual dysfunction.

Since joining the faculty of the University of Texas in 1998, Dr. Meston has focused on women's sexual health issues. With grants from such funding agencies as the Athena Institute of Women's Wellness and the National Center for Complementary and Alternative Medicine, she has investigated the effects of hysterectomy on sexual arousal processes, the effectiveness of gingko biloba for treating antidepressant-induced sexual dysfunction, and the physiological and psychological mechanisms that impact sexual arousal in women. With funding from the National Institute of Child Health and Human Development, Dr. Meston will be exploring the relationship between childhood sexual abuse and adult sexual function and the psychophysiological factors.

Dr. Meston is a past president of the International Society for the Study of Women's Sexual Health and a member of the International Academy of Sex Research, the Society for the Scientific Study of Sex, the American Psychological Association, and the Canadian Psychological Association. She currently serves on the editorial boards of the Archives of Sexual Behavior, the Journal of Sex and Marital Therapy, and the Journal of Sexual Medicine.

Disclosure: advisory committee member - Procter & Gamble Pharmaceuticals; consultant - Procter & Gamble Pharmaceuticals.